Immune monitoring of malignant glioma patients treated with WT1 Trio peptide-based cancer immunotherapy

被引：0

作者：

Kanegae, Mizuki ^{[1
]}

Kagawa, Naoki ^{[1
]}

Kijima, Noriyuki ^{[2
]}

Hirayama, Ryuichi ^{[2
]}

Shimokado, Haruka ^{[1
,2
]}

Nishida, Sumiyuki ^{[3
]}

Hosen, Naoki ^{[4
]}

Tsuboi, Akihiro ^{[5
]}

Oka, Yoshihiro ^{[6
]}

Sugiyama, Haruo ^{[7
]}

Kishima, Haruhiko ^{[8
]}

Oji, Yusuke ^{[1
]}

机构：

[1] Osaka Univ, CLBS, Grad Sch Med, Osaka, Japan

[2] Osaka Univ, NeuroSurg, Grad Sch Med, Osaka, Japan

[3] Osaka Univ, Res Med Clin Imm, Grad Sch Med, Osaka, Japan

[4] Osaka Univ, Hematol Oncol, Grad Sch Med, Osaka, Japan

[5] Osaka Univ, Canc Immther, Grad Sch Med, Osaka, Japan

[6] Osaka Univ, Canc Stem Cell Biol, Grad Sch Med, Osaka, Japan

[7] Osaka Univ, Grad Sch Med, Osaka, Japan

[8] Osaka Univ, NeuroSurg, Grad Sch Med, Osaka, Japan

来源：

CANCER SCIENCE | 2022年 / 113卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P12-2-6

引用

页码：524 / 524

页数：1

共 50 条

[1] Immunomonitoring of rare cancer patients treated with WT1 Trio peptide-based cancer immunotherapy
Hayashi, Sae
Oji, Yusuke
Kagawa, Naoki
Arita, Hideyuki
Shintani, Yasushi
Takeda, Yoshito
Morii, Eiichi
Hamada, Kenichiro
Shimazu, Kenzo
Suzuki, Motoyuki
Imanishi, Rin
Sugiyama, Haruo
CANCER SCIENCE, 2018, 109 : 1275 - 1275
[2] WT1 PEPTIDE-BASED CANCER IMMUNOTHERAPY
Sugiyama, Haruo
JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1017 - 1018
[3] WT1 PEPTIDE-BASED CANCER IMMUNOTHERAPY
Sugiyama, H.
ANNALS OF ONCOLOGY, 2012, 23 : 74 - 74
[4] WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1
Oji, Yusuke
Kagawa, Naoki
Arita, Hideyuki
Naka, Norifumi
Hamada, Ken-ichiro
Outani, Hidetatsu
Shintani, Yasushi
Takeda, Yoshito
Morii, Eiichi
Shimazu, Kenzo
Suzuki, Motoyuki
Nishida, Sumiyuki
Nakata, Jun
Tsuboi, Akihiro
Iwai, Miki
Hayashi, Sae
Imanishi, Rin
Ikejima, Sayaka
Kanegae, Mizuki
Iwamoto, Masahiro
Ikeda, Mayu
Yagi, Kento
Shimokado, Haruka
Nakajima, Hiroko
Hasegawa, Kana
Morimoto, Soyoko
Fujiki, Fumihiro
Nagahara, Akira
Tanemura, Atsushi
Ueda, Yutaka
Mizushima, Tsunekazu
Ohmi, Masato
Ishida, Takayuki
Fujimoto, Manabu
Nonomura, Norio
Kimura, Tadashi
Inohara, Hidenori
Okada, Seiji
Kishima, Haruhiko
Hosen, Naoki
Kumanogoh, Atsushi
Oka, Yoshihiro
Sugiyama, Haruo
CANCERS, 2023, 15 (02)
[5] WT1 peptide-based immunotherapy for patients with lung cancer: Report of two cases
Tsuboi, A
Oka, Y
Osaki, T
Kumagai, T
Tachibana, I
Hayashi, S
Murakami, M
Nakajima, H
Elisseeva, OA
Fei, W
Masuda, T
Yasukawa, M
Oji, Y
Kawakami, M
Hosen, N
Ikegame, K
Yoshihara, S
Udaka, K
Nakatsuka, S
Aozasa, K
Kawase, L
Sugiyama, H
MICROBIOLOGY AND IMMUNOLOGY, 2004, 48 (03) : 175 - 184
[6] Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy
Chisato Yokota
Naoki Kagawa
Koji Takano
Yasuyoshi Chiba
Manabu Kinoshita
Noriyuki Kijima
Yusuke Oji
Yoshihiro Oka
Haruo Sugiyama
Akihiro Tsuboi
Shuichi Izumoto
Haruhiko Kishima
Naoya Hashimoto
Cancer Immunology, Immunotherapy, 2022, 71 : 189 - 201
[7] Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy
Yokota, Chisato
Kagawa, Naoki
Takano, Koji
Chiba, Yasuyoshi
Kinoshita, Manabu
Kijima, Noriyuki
Oji, Yusuke
Oka, Yoshihiro
Sugiyama, Haruo
Tsuboi, Akihiro
Izumoto, Shuichi
Kishima, Haruhiko
Hashimoto, Naoya
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (01) : 189 - 201
[8] WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies
Oji, Yusuke
Inoue, Masayoshi
Takeda, Yoshito
Hosen, Naoki
Shintani, Yasushi
Kawakami, Manabu
Harada, Takuya
Murakami, Yui
Iwai, Miki
Fukuda, Mari
Nishida, Sumiyuki
Nakata, Jun
Nakae, Yoshiki
Takashima, Satoshi
Shirakata, Toshiaki
Nakajima, Hiroko
Hasegawa, Kana
Kida, Hiroshi
Kijima, Takashi
Morimoto, Soyoko
Fujiki, Fumihiro
Tsuboi, Akihiro
Morii, Eiichi
Morita, Satoshi
Sakamoto, Junichi
Kumanogoh, Atsushi
Oka, Yoshihiro
Okumura, Meinoshin
Sugiyama, Haruo
INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (11) : 2375 - 2382
[9] WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine
Alzaaqi, Shouq
Naka, Norifumi
Hamada, Kenichiro
Hosen, Naoki
Kanegae, Mizuki
Outani, Hidetatsu
Adachi, Mayuko
Imanishi, Rin
Morii, Eiichi
Iwai, Miki
Nakata, Jun
Fujiki, Fumihiro
Morimoto, Soyoko
Nakajima, Hiroko
Nishida, Sumiyuki
Tsuboi, Akihiro
Oka, Yoshihiro
Sugiyama, Haruo
Oji, Yusuke
ONCOLOGY LETTERS, 2022, 23 (02)
[10] WT1 Peptide Immunotherapy for Cancer in Children and Young Adults
Hashii, Yoshiko
Sato, Emiko
Ohta, Hideaki
Oka, Yoshihiro
Sugiyama, Haruo
Ozono, Keiichi
PEDIATRIC BLOOD & CANCER, 2010, 55 (02) : 352 - 355

← 1 2 3 4 5 →